Discover the first and only non-adjuvanted feline leukemia virus (FeLV) vaccine to use RNA particle technology to generate an efficient, comprehensive immune Merck Animal Health announced the launch of these vaccines, Nobivac® NXT Canine Flu H3N2 and Nobivac® NXT FeLV, both of which rely on RNA
Nobivac® NXT FeLV is a non-adjuvanted, freeze-dried injectable feline leukemia virus vaccine, utilizing RNA particle technology. The vaccine stimulates NOBIVAC NXT FeLV is a nonadjuvanted, low volume 0.5 mL dose vaccination that uses the immune system's natural strengths to preserve comfort and safety. Enter the NXT-era of adjuvant-free FeLV protection for cats with Nobivac® NXT FeLV, the first and only feline leukemia virus vaccine built on RNA particle
Nobivac® NXT FeLV - Merck Animal Health USA mRNA vaccines for pets. NOBIVAC NXT FeLV is the first and only feline leukemia virus vaccine built on Merck Animal Health's RNA-particle technology platform and is designed to deliver
Merck Animal Health's Ground-breaking FeLV Vaccine New vaccine protects against feline leukemia virus | dvm360
Product Code: 1555R8. Product True Name: Feline Leukemia Vaccine, RNA Particle. Agent(s): Feline Leukemia Virus. Trade Name(s): Nobivac NXT FeLV. "NOBIVAC NXT FeLV becomes the only vaccine against FeLV to be Feline Products
165A-1555R8 | Animal and Plant Health Inspection Service PRODUCT DESCRIPTION: Nobivac ® NXT FeLV is a non-adjuvanted, freeze-dried injectable feline leukemia virus vaccine, utilizing RNA particle technology. The Nobivac® NXT FeLV is a feline leukemia vaccine for cats designed to protect your cat from the potentially devastating effects of the feline leukemia virus (FeLV)
RNA vaccines: the way of the future? NOBIVAC® NXT FeLV
SELF-AMPLIFYING mRNA Not for humans this time. For your cats and dogs. In June 2024, the USDA approved Merck's 1 The vaccine is intended to be administered in 2 doses, separated by 3 to 4 weeks, according to the label and the recommendation of the Nobivac NXT FeLV for Cats - Drugs.com